You are here: Industry Insights > Protein

News List

Amgen, Generate Biomedicines partner to create protein therapeutics pharmaceutical-business-review
January 07, 2022
Amgen has entered into a research collaboration agreement with Generate Biomedicines...
Amgen, Generate Biomedicines Enter Protein Therapeutics Pact contractphrma
January 06, 2022
Aims to discover and create protein therapeutics for five clinical targets across several therapeutic areas and multiple modalities.
Decode Genetics Publishes the Largest Ever Study of the Plasma Proteome prnasia
December 03, 2021
In a study published today in Nature genetics, scientists at deCODE genetics , a subsidiary of the pharmaceutical company Amgen, demonstrate how measuring the levels of a large number of proteins...
Cell-free protein synthesis could enable decentralised conjugate vaccine production EuropeanPharmaceuticalReview
November 22, 2021
According to the developers, iVAX – a modular technology for in vitro conjugate vaccine expression – is portable and could overcome the challenges of ensuring cold-chain supply of conjugate vaccine products...
Protein catenation to advance development of therapeutic proteins EuropeanPharmaceuticalReview
November 17, 2021
According to a new paper, topology engineering holds great promise in the development of therapeutic proteins. In the study, Wu et al. biosynthesised artificial antibodies...
Hill's Pet Nutrition Partners With Bond Pet Foods, Inc. To Develop A Craft Meat Protein Produced Through Precision Fermentation prnasia
November 15, 2021
Hill's Pet Nutrition, a global leader in biology-based pet nutrition, and Bond Pet Foods, Inc., the Boulder-based leader in creating meat proteins via fermentation for pet food applications...
BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs prnasia
September 23, 2021
BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that global CDMO partner WuXi Biologics, has completed the synthesis of recombinant SARS-CoV-2 s-protein for BVX-0320...
Prof. Ernst Wagner Joins Coriolis Pharma’s Scientific Advisory Board as Expert for Nucleic Acid Therapeutics b3cnewswire
June 15, 2021
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, today announced that Prof. Dr. Ernst Wagner has joined its scientific advisory board.
Protein identified as new therapeutic anti-viral target for COVID-19 worldpharmanews
June 10, 2021
New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new therapeutic anti-viral target.
Using albumin could facilitate vaccination by inhalation, finds pre-clinical study europeanpharmaceuticalreview
March 24, 2021
MIT researchers developed and tested in mice intratracheal vaccines to protect against the vaccinia virus and the formation of lung cancer.

Previous page 1 2 3 4 5 6 7 8 9 Next page